← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2012Last known activity
May 1, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT03476564CollaboratorEarly Phase 1May 1, 2018
- NCT02226588CollaboratorPhase 4Oct 1, 2014
- NCT02226588Overall official - principal investigatorPhase 4Oct 1, 2014
- NCT01914419CollaboratorN/AApr 1, 2014
- NCT02086838Overall official - principal investigatorPhase 4Jul 1, 2013
- NCT01619072Overall official - principal investigatorN/ANov 30, 2012
- NCT01619072CollaboratorN/ANov 30, 2012
- NCT01619072OfficialN/ANov 30, 2012
Details
- Last known activity
- May 1, 2018